ecancer

Towards delivering truly personalised therapy for oesophageal cancer

Prof Tim Underwood - University of Southampton, Southampton, UK

23 Nov 2016

Managing breast cancer in low and middle income countries

Dr Cheng-Har Yip - President, Breast Surgery International

23 Nov 2016

Therapeutic targeting of childhood medulloblastoma

Dr Sheila Singh - McMaster University, Hamilton, Canada

23 Nov 2016

Improving the evidence base for symptom control

Prof David Currow - Flinders University, Adelaide, Australia

23 Nov 2016

Prof Kaye: CRUK lifetime achievement award winner

Prof Stan Kaye - The Institute of Cancer Research, London, UK

23 Nov 2016

Improving analysis of functional imaging

Prof Nandita deSouza - The Institute of Cancer Research, London, UK

23 Nov 2016

Highlights from NCRI 2016

Dr Karen Kennedy - Director, NCRI

23 Nov 2016

Abiraterone vs docetaxel for metastatic castrate resistant prostate cancer

Dr Shabbir Alibhai - Princess Margaret Cancer Centre, Toronto, Canada

22 Nov 2016

Advancements in the field of geriatric oncology

Dr Stuart Lichtman - Memorial Sloan Kettering Cancer Center, New York, USA

22 Nov 2016

The creation of SIOG, and a systematic review of the AML literature

Dr Martine Extermann - Moffitt Cancer Center, Tampa, USA

22 Nov 2016

AML: Is less as good as more?

Dr Rebecca Olin - University of California San Francisco, San Francisco,, USA

22 Nov 2016

Target mutations in lung cancer

Dr Romain Corre - Rennes University Hospital, Rennes, France

22 Nov 2016

More from ecancer